INS and metabolic disease: IR, a defective response to insulin stimulation of target cells such as hepatocytes, skeletal muscle cells, and adipocytes, plays a crucial role in the development of several metabolic diseases including T2DM, obesity, metabolic dysfunction-associated fatty liver disease, and dyslipidemia [2].